List of Tables
Table 1. Global Nervous System Chemicals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nervous System Chemicals Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nervous System Chemicals Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nervous System Chemicals Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nervous System Chemicals Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nervous System Chemicals Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nervous System Chemicals Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nervous System Chemicals Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nervous System Chemicals, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nervous System Chemicals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nervous System Chemicals, Product Type & Application
Table 12. Global Key Manufacturers of Nervous System Chemicals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nervous System Chemicals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Chemicals as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nervous System Chemicals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nervous System Chemicals Sales by Region (2020-2025) & (K Units)
Table 18. Global Nervous System Chemicals Sales Market Share by Region (2020-2025)
Table 19. Global Nervous System Chemicals Sales by Region (2026-2031) & (K Units)
Table 20. Global Nervous System Chemicals Sales Market Share by Region (2026-2031)
Table 21. Global Nervous System Chemicals Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nervous System Chemicals Revenue Market Share by Region (2020-2025)
Table 23. Global Nervous System Chemicals Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nervous System Chemicals Revenue Market Share by Region (2026-2031)
Table 25. North America Nervous System Chemicals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nervous System Chemicals Sales by Country (2020-2025) & (K Units)
Table 27. North America Nervous System Chemicals Sales by Country (2026-2031) & (K Units)
Table 28. North America Nervous System Chemicals Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nervous System Chemicals Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nervous System Chemicals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nervous System Chemicals Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nervous System Chemicals Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nervous System Chemicals Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nervous System Chemicals Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nervous System Chemicals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nervous System Chemicals Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nervous System Chemicals Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nervous System Chemicals Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nervous System Chemicals Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nervous System Chemicals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nervous System Chemicals Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nervous System Chemicals Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nervous System Chemicals Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nervous System Chemicals Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nervous System Chemicals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nervous System Chemicals Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nervous System Chemicals Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nervous System Chemicals Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nervous System Chemicals Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nervous System Chemicals Sales (K Units) by Type (2020-2025)
Table 51. Global Nervous System Chemicals Sales (K Units) by Type (2026-2031)
Table 52. Global Nervous System Chemicals Sales Market Share by Type (2020-2025)
Table 53. Global Nervous System Chemicals Sales Market Share by Type (2026-2031)
Table 54. Global Nervous System Chemicals Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nervous System Chemicals Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nervous System Chemicals Revenue Market Share by Type (2020-2025)
Table 57. Global Nervous System Chemicals Revenue Market Share by Type (2026-2031)
Table 58. Global Nervous System Chemicals Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nervous System Chemicals Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nervous System Chemicals Sales (K Units) by Application (2020-2025)
Table 61. Global Nervous System Chemicals Sales (K Units) by Application (2026-2031)
Table 62. Global Nervous System Chemicals Sales Market Share by Application (2020-2025)
Table 63. Global Nervous System Chemicals Sales Market Share by Application (2026-2031)
Table 64. Global Nervous System Chemicals Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nervous System Chemicals Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nervous System Chemicals Revenue Market Share by Application (2020-2025)
Table 67. Global Nervous System Chemicals Revenue Market Share by Application (2026-2031)
Table 68. Global Nervous System Chemicals Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nervous System Chemicals Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Nervous System Chemicals Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Ely Lilly Company Information
Table 76. Ely Lilly Description and Business Overview
Table 77. Ely Lilly Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Ely Lilly Nervous System Chemicals Product
Table 79. Ely Lilly Recent Developments/Updates
Table 80. Actavis(Teva Pharmaceuticals) Company Information
Table 81. Actavis(Teva Pharmaceuticals) Description and Business Overview
Table 82. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product
Table 84. Actavis(Teva Pharmaceuticals) Recent Developments/Updates
Table 85. Mylan(Viatris) Company Information
Table 86. Mylan(Viatris) Description and Business Overview
Table 87. Mylan(Viatris) Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Mylan(Viatris) Nervous System Chemicals Product
Table 89. Mylan(Viatris) Recent Developments/Updates
Table 90. UCB Company Information
Table 91. UCB Description and Business Overview
Table 92. UCB Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. UCB Nervous System Chemicals Product
Table 94. UCB Recent Developments/Updates
Table 95. Intellipharmaceutics Company Information
Table 96. Intellipharmaceutics Description and Business Overview
Table 97. Intellipharmaceutics Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Intellipharmaceutics Nervous System Chemicals Product
Table 99. Intellipharmaceutics Recent Developments/Updates
Table 100. Astrazeneca Company Information
Table 101. Astrazeneca Description and Business Overview
Table 102. Astrazeneca Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Astrazeneca Nervous System Chemicals Product
Table 104. Astrazeneca Recent Developments/Updates
Table 105. Lundbeck Company Information
Table 106. Lundbeck Description and Business Overview
Table 107. Lundbeck Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Lundbeck Nervous System Chemicals Product
Table 109. Lundbeck Recent Developments/Updates
Table 110. Allergan(AbbVie) Company Information
Table 111. Allergan(AbbVie) Description and Business Overview
Table 112. Allergan(AbbVie) Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Allergan(AbbVie) Nervous System Chemicals Product
Table 114. Allergan(AbbVie) Recent Developments/Updates
Table 115. GSK Company Information
Table 116. GSK Description and Business Overview
Table 117. GSK Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. GSK Nervous System Chemicals Product
Table 119. GSK Recent Developments/Updates
Table 120. Otsuka Pharmaceutical Company Information
Table 121. Otsuka Pharmaceutical Description and Business Overview
Table 122. Otsuka Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Otsuka Pharmaceutical Nervous System Chemicals Product
Table 124. Otsuka Pharmaceutical Recent Developments/Updates
Table 125. Takeda Company Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Takeda Nervous System Chemicals Product
Table 129. Takeda Recent Developments/Updates
Table 130. Novartis Company Information
Table 131. Novartis Description and Business Overview
Table 132. Novartis Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Novartis Nervous System Chemicals Product
Table 134. Novartis Recent Developments/Updates
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Johnson & Johnson Nervous System Chemicals Product
Table 139. Johnson & Johnson Recent Developments/Updates
Table 140. Eisai Company Information
Table 141. Eisai Description and Business Overview
Table 142. Eisai Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Eisai Nervous System Chemicals Product
Table 144. Eisai Recent Developments/Updates
Table 145. Kelun Pharmaceutical Company Information
Table 146. Kelun Pharmaceutical Description and Business Overview
Table 147. Kelun Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Kelun Pharmaceutical Nervous System Chemicals Product
Table 149. Kelun Pharmaceutical Recent Developments/Updates
Table 150. Humanwell Pharmaceutical Company Information
Table 151. Humanwell Pharmaceutical Description and Business Overview
Table 152. Humanwell Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Humanwell Pharmaceutical Nervous System Chemicals Product
Table 154. Humanwell Pharmaceutical Recent Developments/Updates
Table 155. Enhua Pharmaceutical Company Information
Table 156. Enhua Pharmaceutical Description and Business Overview
Table 157. Enhua Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Enhua Pharmaceutical Nervous System Chemicals Product
Table 159. Enhua Pharmaceutical Recent Developments/Updates
Table 160. Yangzijiang Pharmaceutical Company Information
Table 161. Yangzijiang Pharmaceutical Description and Business Overview
Table 162. Yangzijiang Pharmaceutical Nervous System Chemicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Yangzijiang Pharmaceutical Nervous System Chemicals Product
Table 164. Yangzijiang Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Nervous System Chemicals Distributors List
Table 168. Nervous System Chemicals Customers List
Table 169. Nervous System Chemicals Market Trends
Table 170. Nervous System Chemicals Market Drivers
Table 171. Nervous System Chemicals Market Challenges
Table 172. Nervous System Chemicals Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nervous System Chemicals
Figure 2. Global Nervous System Chemicals Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nervous System Chemicals Market Share by Type: 2024 & 2031
Figure 4. Non-prescription Drugs Product Picture
Figure 5. Prescription Product Picture
Figure 6. Global Nervous System Chemicals Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Nervous System Chemicals Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Nervous System Chemicals Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Nervous System Chemicals Market Size (2020-2031) & (US$ Million)
Figure 13. Global Nervous System Chemicals Sales (2020-2031) & (K Units)
Figure 14. Global Nervous System Chemicals Average Price (US$/Unit) & (2020-2031)
Figure 15. Nervous System Chemicals Report Years Considered
Figure 16. Nervous System Chemicals Sales Share by Manufacturers in 2024
Figure 17. Global Nervous System Chemicals Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Nervous System Chemicals Players: Market Share by Revenue in Nervous System Chemicals in 2024
Figure 19. Nervous System Chemicals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Nervous System Chemicals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Nervous System Chemicals Sales Market Share by Country (2020-2031)
Figure 22. North America Nervous System Chemicals Revenue Market Share by Country (2020-2031)
Figure 23. United States Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Nervous System Chemicals Sales Market Share by Country (2020-2031)
Figure 26. Europe Nervous System Chemicals Revenue Market Share by Country (2020-2031)
Figure 27. Germany Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Nervous System Chemicals Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Nervous System Chemicals Revenue Market Share by Region (2020-2031)
Figure 34. China Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Nervous System Chemicals Sales Market Share by Country (2020-2031)
Figure 42. Latin America Nervous System Chemicals Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Nervous System Chemicals Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Nervous System Chemicals Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Nervous System Chemicals Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Nervous System Chemicals by Type (2020-2031)
Figure 52. Global Revenue Market Share of Nervous System Chemicals by Type (2020-2031)
Figure 53. Global Nervous System Chemicals Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Nervous System Chemicals by Application (2020-2031)
Figure 55. Global Revenue Market Share of Nervous System Chemicals by Application (2020-2031)
Figure 56. Global Nervous System Chemicals Price (US$/Unit) by Application (2020-2031)
Figure 57. Nervous System Chemicals Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
